Page 89 - Read Online

Page 6 of 6 Kurt et al. J Cancer Metastasis Treat 2019;5:8 I http://dx.doi.org/10.20517/2394-4722.2018.80

Ethical approval and consent to participate
The consent form was signed by the patient herself. We foresee no ethical issues regarding the publication of
this case report.

Consent for publication
The consent form was signed by the patient herself.

Copyright
© The Author(s) 2019.

REFERENCES
1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 201;64:9-29.
2. Bianchi S, Vezzosi V. Microinvasive carcinoma of the breast. Pathol Oncol Res 2008;14:105-11.
3. Hanna MG, Jaffer S, Bleiweiss IJ, Nayak A. Re-evaluating the role of sentinel lymph node biopsy in microinvasive breast carcinoma. Mod
Pathol 2014;27:1489-98.
4. Kuhar CG, Matos E. Human epidermal growth factor receptor 2-positive microinvasive breast carcinoma with a highly aggressive course: a
case report. BMC Res Notes 2014;7:325.
5. Sánchez-Muñoz A, Pérez-Ruiz E, Jurado JM, Ribelles N, Márquez A, et al. Prognosis of microinvasive breast carcinoma with negative
axillary nodes in accordance with TNM classification criteria. Breast J 2010;16:669-71.
6. Costarelli L, Cianchetti E, Corsi F, Friedman D, Ghilli M, et al. Microinvasive breast carcinoma: an analysis from ten Senonetwork Italia
breast centres. Eur J Surg Oncol 2018; doi: 10.1016/j.ejso.2018.09.024.
7. Parikh RR, Haffty BG, Lannin D, Moran MS. Ductal carcinoma in situ with microinvasion: Prognostic implications, long-term outcomes,
and role of axillary evaluation. Int J Radiat Oncol Biol Phys 2012;82:7-13.
8. Samiee S, Berardi P, Bouganim N, Vandermeer L, Arnaout A, et al. Excision of the primary tumour in patients with metastatic breast cancer:
a clinical dilemma. Curr Oncol 2012;19:e270-9.
9. Arslan D, Tural D, Tatlı AM, Akar E, Uysal M, et al. Isolated uterine metastasis of invasive ductal carcinoma. Case Rep Oncol Med
2013;2013:793418.
10. Wang W, Zhu W, Du F, Luo Y, Xu B. The demographic features, clinicopathological characteristics and cancer-specific outcomes for
patients with microinvasive breast cancer: a SEER database analysis. Sci Rep 2017;7:42045.
11. Kitajima K, Suzuki K, Senda M, Kita M, Onishi Y, et al. FDG PET/CT features of ovarian metastasis. Clin Radiol 2011;66:264-8.
12. Kurt S, Ulukuş Ç, Kazaz SN, Astarcıoğlu İ. Bilateral ovarian metastasis of a Klatskin tumor: a rare case. Turk J Soc Obstet Gynecol
2016;13:215-7.
13. Matsushita H, Watanabe K, Wakatsuki A. Metastatic gastric cancer to the female genital tract. Mol Clin Oncol 2016;5:495-9.
14. Turan T, Aykan B, Koc S, Boran N, Tulunay G, et al. Analysis of metastatic ovarian tumors from extragenital primary sites. Tumori
2006;92:491-5.
15. Kurt S, Canda MT, Kopuz A, Demirtaş Ö, Taşyurt A. Adnexal masses: retrospective assessment of 424 cases and review of the literature.
Turkiye Klin J Gynecol Obstet 2016;26:209-13.
16. Wang L, Zhang W, Lyu S, Liu X, Zhang T, et al. Clinicopathologic characteristics and molecular subtypes of microinvasive carcinoma of
the breast. Tumor Biol 2015;36:2241-8.